Phillip Wong

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 22 papers. Top paper: “Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab”.

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab

JAMA Oncology(2020)10.1001/jamaoncol.2019.6152

N/A

5.0DataRank · unranked

207 citations

Cristina R. Antonescu, Timothy G. Bowler, Rodrigo Ramella Munhoz, Ping Chi, Mark A. Dickson +21 more

Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child

Nature Medicine(2021)10.1038/s41591-021-01388-5

N/A

2.7DataRank · unranked

113 citations

Rui Yang, Caner Aytekin, David Langlais, Mathieu Bourgey, Taushif Khan +50 more

Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0855

N/A

2.2DataRank · unranked

68 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma

Nature Communications(2022)10.1038/s41467-022-29342-0

N/A

2.1DataRank · unranked

82 citations

Samuel A. Funt, Annie Borch, Kamilla Kjærgaard Munk, Anne-Mette Bjerregaard, James L. Reading +17 more

Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases

npj Breast Cancer(2022)10.1038/s41523-022-00404-2

N/A

0.996DataRank · unranked

31 citations

Kathryn Beal, Stefanie N. Linch, Kateri J. Spinelli, Micaela Rodine, Darragh Halpenny +12 more

Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0339

N/A

0.587DataRank · unranked

49 citations

Roberta Zappasodi, Hong Wang, Girish S. Naik, Takami Sato, Todd M. Bauer +13 more

A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3936

N/A

0.571DataRank · unranked

44 citations

Susan J. Knox, Debra A. Goldman, Yuval Elhanati, Vikram Mavinkurve, Phillip Wong +20 more

T cell receptor diversity evaluation to predict patient response to Ipilimumab in metastatic melanoma

Journal for ImmunoTherapy of Cancer(2014)10.1186/2051-1426-2-s3-o8

N/A

0.269DataRank · unranked

5 citations

Manuarii Manuel, Phillip Wong, Jianda Yuan, Marlene Noel, Anais Courtier +3 more

Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9536

N/A

0.115DataRank · unranked

1 citations

Mark Klang, Michael A. Postow, Alexander N. Shoushtari, Ryan J. Sullivan, Jedd D. Wolchok +4 more

Treatment with Tumor-Treating Fields (TTFields) Suppresses Intercellular Tunneling Nanotube Formation In Vitro and Upregulates Immuno-Oncologic Biomarkers In Vivo in Malignant Mesothelioma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.29.522223

N/A

0DataRank · unranked

0 citations

Sophie Korenfeld, Karina Deniz, Katherine J. Ladner, Phillip Wong, Sanyukta Padmanabhan +7 more

Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission

Cancers(2023)10.3390/cancers15051458

N/A

0DataRank · unranked

20 citations

Sacha Gnjatic, Carol Aghajanian, Jason Konner, Sarah H. Kim, Debra Sarasohn +12 more

Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma

eLife(2023)10.7554/elife.85383

N/A

0DataRank · unranked

16 citations

Sophie Korenfeld, Karina Deniz, Katherine J. Ladner, Phillip Wong, Sanyukta Padmanabhan +7 more

Neuroimaging and Neurocognitive Outcomes in Older Patients with Multiple Myeloma Treated with Chemotherapy and Autologous Stem Cell Transplantation

Research Square(2023)10.21203/rs.3.rs-2733807/v1

N/A

0DataRank · unranked

1 citations

Behroze Vachha, Raymond E. Baser, Adrian Koch, Phillip Wong, Suril Gohel +3 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578.v1

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Systemic Immunological Changes After Yttrium-90 Radioembolization: A Pilot Prospective Observational Study—Clinical Insights

CardioVascular and Interventional Radiology(2024)10.1007/s00270-024-03870-2

N/A

0DataRank · unranked

4 citations

Elena N. Petre, Phillip Wong, Vlasios S. Sotirchos, Efsevia Vakiani, Platon Dimopoulos +4 more

Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer

iScience(2024)10.1016/j.isci.2024.108880

N/A

0DataRank · unranked

7 citations

Sadna Budhu, Yuval Elhanati, David B. Page, Teresa Rasalan-Ho, Erika Ritter +11 more

Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110320

N/A

0DataRank · unranked

2 citations

Xiaojing Huang, Stephanie Lobaugh, Zhigang Zhang, Phillip Wong, Alexander Geyer +10 more

Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients

Journal of Geriatric Oncology(2025)10.1016/j.jgo.2025.102346

N/A

0DataRank · unranked

1 citations

Phillip Wong, Jessica Flynn, Erika Ritter, Caleb Ho, Josel D. Ruiz +11 more

SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancer

iScience(2025)10.1016/j.isci.2025.113438

N/A

0DataRank · unranked

1 citations

Christine Luo, Katherine J. Ladner, Allison Makovec, Phillip Wong, Jeremy M. Chacón +14 more

A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100440

N/A

0DataRank · unranked

6 citations

Prasad S. Adusumilli, Michael Offin, Stephen B. Solomon, Etay Ziv, Sara A. Hayes +22 more

Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas

Nature Communications(2022)10.1038/s41467-022-33719-6

N/A

0DataRank · unranked

19 citations

Jia Luo, Ni Ai, Rachel Kim, Linda S. Ahn, Anup Biswas +10 more